Kevin Caliendo

Q: What is Kevin Caliendo's success rate?

Kevin Caliendo currently has a success rate of 84.49643334226637.

Q: What is the average return of Kevin Caliendo's calls?

Their stock ratings have generated an average return of 7.945709279126738.

UBS | Healthcare

Kevin Caliendo is an analyst from UBS specializing in the Healthcare sector. Ranked #2014 out of 4535 analysts, they have issued 50 stock ratings with a success rate of 84.50% and an average return of 7.95%.

Kevin Caliendo has a well-established track record, with 50 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 84.50% and an average return of 7.95%, underscoring their expertise and ability to identify winning opportunities for investors.

#2014

Out of 4535

Total Ratings

+84.50%

Success Rate

+7.95%

Average Return

Recent Ratings Analysis

ALGN

Hold

Feb 05, 2026

Target

$185.00

Current

$175.62

Performance

0.00%

Kevin Caliendo rated ALGN as Neutral on Feb 05, 2026, setting a price target of 185. The Hold stance appears justified, as shares hovered around 175.62 with a 0.00% move.

XRAY

Buy

Feb 03, 2026

Target

$16.00

Current

$12.53

Performance

4.42%

On Feb 03, 2026, XRAY was given a Buy rating by Kevin Caliendo, with a target price of 16. The stock traded sideways with a 4.42% move, keeping the bullish thesis unresolved.

NVST

Hold

Feb 03, 2026

Target

$25.00

Current

$24.71

Performance

7.86%

NVST received a Neutral rating from Kevin Caliendo on Feb 03, 2026, aiming for 25. Investors saw gains of 7.86% that the cautious stance didn’t fully capture.

ALHC

Hold

Jan 14, 2026

Target

$21.00

Current

$21.15

Performance

-2.76%

On Jan 14, 2026, Kevin Caliendo published a Neutral outlook on ALHC, with a target of 21. Sideways action left the Hold view intact, with no major move since 21.15.

MDLN

Buy

Jan 12, 2026

Target

$48.00

Current

$46.20

Performance

8.15%

Kevin Caliendo on Jan 12, 2026 assigned MDLN a Buy rating, with a price target of 48. The Buy call aligned well with market performance, producing a gain of 8.15%.

CVS

Buy

Dec 10, 2025

Target

$97.00

Current

$76.33

Performance

-3.34%

On Dec 10, 2025, Kevin Caliendo reaffirmed CVS with a Buy rating, targeting 97. Market indecision has kept the 97 target in a holding pattern.

SOLV

Hold

Nov 10, 2025

Target

$79.00

Current

$76.98

Performance

7.23%

SOLV was rated Neutral by Kevin Caliendo on Nov 10, 2025, with a price objective of 79. Despite caution, upside momentum rewarded risk-takers with gains to 76.98.

LFST

Buy

Nov 07, 2025

Target

$10.00

Current

$6.54

Performance

3.97%

On Nov 07, 2025, Kevin Caliendo initiated coverage on LFST with a Buy rating and target of 10. Neutral price movement of 3.97% leaves room for interpretation.

COR

Buy

Nov 07, 2025

Target

$415.00

Current

$352.16

Performance

-2.37%

Kevin Caliendo issued a Buy recommendation for COR on Nov 07, 2025, price target set at 415. The target of 415 remains in play, though confirmation will depend on future moves.

MCK

Buy

Nov 06, 2025

Target

$980.00

Current

$957.80

Performance

11.55%

On Nov 06, 2025, MCK was evaluated by Kevin Caliendo, who gave a Buy rating and target of 980. This case illustrates how a timely bullish rating can translate into tangible gains of 11.55%.

GDRX

Hold

Nov 06, 2025

Target

$4.00

Current

$2.29

Performance

-27.53%

Kevin Caliendo rated GDRX as Neutral on Nov 06, 2025, setting a price target of 4. The cautious Hold call aligned with subsequent weakness, as shares slipped 27.53%.

OMI

Hold

Nov 03, 2025

Target

$4.00

Current

$2.68

Performance

-22.32%

On Nov 03, 2025, OMI was given a Neutral rating by Kevin Caliendo, with a target price of 4. The rating provided protection from downside risk as the stock fell to 2.68.

CAH

Buy

Oct 31, 2025

Target

$220.00

Current

$227.18

Performance

19.09%

CAH received a Buy rating from Kevin Caliendo on Oct 31, 2025, aiming for 220. Momentum has favored the Buy call, with shares climbing from 227.18 to 227.18, rewarding those who trusted the recommendation.

UNH

Buy

Oct 29, 2025

Target

$430.00

Current

$268.55

Performance

-24.41%

On Oct 29, 2025, Kevin Caliendo published a Buy outlook on UNH, with a target of 430. Market action contradicted the Buy thesis, as shares slipped to 268.55.

LH

Buy

Oct 29, 2025

Target

$320.00

Current

$278.23

Performance

12.13%

Kevin Caliendo on Oct 29, 2025 assigned LH a Buy rating, with a price target of 320. The Buy call aligned well with market performance, producing a gain of 12.13%.

MOH

Hold

Oct 24, 2025

Target

$170.00

Current

$176.81

Performance

8.26%

On Oct 24, 2025, Kevin Caliendo reaffirmed MOH with a Neutral rating, targeting 170. Market strength beyond 176.81 went further than the conservative outlook suggested.

DGX

Hold

Oct 17, 2025

Target

$190.00

Current

$192.30

Performance

1.47%

DGX was rated Neutral by Kevin Caliendo on Oct 17, 2025, with a price objective of 190. Flat performance suggests the Hold view was reasonable.

PINC

Hold

Sep 25, 2025

Target

$28.25

Current

$28.26

Performance

1.69%

On Sep 25, 2025, Kevin Caliendo initiated coverage on PINC with a Neutral rating and target of 28.25. The stock’s lack of movement around 28.26 aligned with a cautious approach.

HSIC

Hold

Aug 06, 2025

Target

$70.00

Current

$77.00

Performance

16.10%

Kevin Caliendo issued a Neutral recommendation for HSIC on Aug 06, 2025, price target set at 70. A neutral call gave way to stronger-than-expected performance, closing in on 70.

AMWL

Hold

May 08, 2025

Target

$9.00

Current

$4.25

Performance

-38.94%

On May 08, 2025, AMWL was evaluated by Kevin Caliendo, who gave a Neutral rating and target of 9. The Hold call avoided chasing into subsequent weakness of 38.94%.

CI

Buy

Feb 03, 2025

Target

$390.00

Current

$284.53

Performance

-2.71%

Kevin Caliendo rated CI as Buy on Feb 03, 2025, setting a price target of 390. Shares have remained stable near 284.53, leaving the 390 target still in play.

EVH

Buy

Jan 16, 2025

Target

$14.00

Current

$2.89

Performance

-71.56%

On Jan 16, 2025, EVH was given a Buy rating by Kevin Caliendo, with a target price of 14. Despite the Buy call, shares fell from 2.89 to 2.89, challenging the optimistic stance.

WBA

Hold

Oct 17, 2024

Target

$10.00

Current

$11.98

Performance

12.38%

WBA received a Neutral rating from Kevin Caliendo on Oct 17, 2024, aiming for 10. Investors saw gains of 12.38% that the cautious stance didn’t fully capture.

HUM

Hold

Oct 04, 2024

Target

$250.00

Current

$193.55

Performance

-19.36%

On Oct 04, 2024, Kevin Caliendo published a Neutral outlook on HUM, with a target of 250. Weakness in the stock, now at 193.55, supported the conservative rating.

Frequency Asked Questions

Who is Kevin Caliendo?

Kevin Caliendo is an analyst from UBS specializing in the Healthcare sector.

What is Kevin Caliendo's success rate?

Kevin Caliendo currently has a success rate of +84.50%.

How many ratings has Kevin Caliendo issued?

Kevin Caliendo has issued 50 stock ratings so far.

What is the average return of Kevin Caliendo's calls?

Their stock ratings have generated an average return of +7.95%.

What is Kevin Caliendo's ranking?

Kevin Caliendo is ranked #2014 out of 4535 analysts.

What types of ratings does Kevin Caliendo give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Kevin Caliendo?

You can follow Kevin Caliendo by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Kevin Caliendo?

Their latest rating was a Hold on ALGN issued on 2026-02-05.